Every open market buy and sale of Solid Biosciences Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $2.7M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when SLDB insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an SLDB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every SLDB insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Gabriel BrooksChief Medical Officer | Sale plan | 4,374 | $5.62 | $25K | 97,241 | Oct 20Form 4 |
| Feb 18, 2026 | Kevin TanCFO & Treasurer | Sale plan | 5,404 | $5.82 | $31K | 99,422 | Feb 18Form 4 |
| Feb 18, 2026 | David T HowtonCOO | Sale plan | 7,469 | $5.82 | $43K | 105,077 | Feb 18Form 4 |
| Feb 18, 2026 | Paul HerzichChief Technology Officer | Sale plan | 3,616 | $5.82 | $21K | 72,638 | Feb 18Form 4 |
| Feb 18, 2026 | Ilan GanotDirector | Sale plan | 2,658 | $5.82 | $15K | 27,474 | Feb 18Form 4 |
| Feb 18, 2026 | Jessie HanrahanChief Regulatory Officer | Sale plan | 4,134 | $5.82 | $24K | 74,318 | Feb 18Form 4 |
| Feb 18, 2026 | Alexander CumboPresident and CEO | Sale plan | 16,644 | $5.82 | $97K | 235,405 | Feb 18Form 4 |
| Feb 4, 2026 | Paul HerzichChief Technology Officer | Sale plan | 10,905 | $6.44 | $70K | 69,067 | Feb 6Form 4 |
| Feb 4, 2026 | Jessie HanrahanChief Regulatory Officer | Sale plan | 12,348 | $6.44 | $80K | 70,327 | Feb 6Form 4 |
| Feb 4, 2026 | Gabriel BrooksChief Medical Officer | Sale plan | 12,616 | $6.44 | $81K | 84,092 | Feb 6Form 4 |
| Feb 4, 2026 | Kevin TanCFO & Treasurer | Sale plan | 14,783 | $6.44 | $95K | 94,201 | Feb 6Form 4 |
| Feb 4, 2026 | Ilan GanotDirector | Sale plan | 7,205 | $6.44 | $46K | 25,271 | Feb 6Form 4 |
| Feb 4, 2026 | Alexander CumboPresident and CEO | Sale plan | 48,913 | $6.44 | $315K | 222,018 | Feb 6Form 4 |
| Feb 4, 2026 | David T HowtonCOO | Sale plan | 18,894 | $6.44 | $122K | 97,859 | Feb 6Form 4 |
| Feb 2, 2026 | Paul HerzichChief Technology Officer | Sale plan | 26,250 | $6.44 | $169K | 79,972 | Feb 2Form 4 |
SLDB insider trading FAQ
Are SLDB insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of SLDB on the open market in 0 trades, and 7 sold $2.7M in 27 trades, 100% of that under pre-arranged trading plans.
When did an SLDB insider last buy shares?
Clare Kahn (Director) bought 1,860 shares for $10K on Mar 11, 2025, reported on Mar 13, 2025.
When did an SLDB insider last sell shares?
Gabriel Brooks (Chief Medical Officer) sold 4,374 shares for $25K on Oct 19, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
